These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15357964)

  • 1. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of agonists and antagonists of the human melanocortin-4 receptor from piperazinebenzylamines.
    Tran JA; Pontillo J; Arellano M; White NS; Fleck BA; Marinkovic D; Tucci FC; Lanier M; Nelson J; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Feb; 15(3):833-7. PubMed ID: 15664867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
    Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
    J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Nelson J; Parker J; Saunders J; Murphy B; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5605-9. PubMed ID: 15482933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of piperazinebenzylamines with a N-(1-methoxy-2-propyl) side chain as potent and selective antagonists of the human melanocortin-4 receptor.
    Pontillo J; Marinkovic D; Tran JA; Arellano M; Fleck BA; Wen J; Tucci FC; Nelson J; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4615-8. PubMed ID: 16105734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.
    Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.
    Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
    Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor.
    Jiang W; Tucci FC; Chen CW; Arellano M; Tran JA; White NS; Marinkovic D; Pontillo J; Fleck BA; Wen J; Saunders J; Madan A; Foster AC; Chen C
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4674-8. PubMed ID: 16777413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; White NS; Arellano M; Fleck BA; Marinkovic D; Tucci FC; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5237-40. PubMed ID: 16183282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
    Marinkovic D; Tucci FC; Tran JA; Fleck BA; Wen J; Chen C
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4817-22. PubMed ID: 18682322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.
    Pontillo J; Tran JA; Markison S; Joppa M; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Nelson J; Saunders J; Hoare SR; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 May; 15(10):2541-6. PubMed ID: 15863313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.
    Chen CW; Tran JA; Fleck BA; Tucci FC; Jiang W; Chen C
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6825-31. PubMed ID: 17964151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.
    Chen C; Tucci FC; Jiang W; Tran JA; Fleck BA; Hoare SR; Wen J; Chen T; Johns M; Markison S; Foster AC; Marinkovic D; Chen CW; Arellano M; Harman J; Saunders J; Bozigian H; Marks D
    Bioorg Med Chem; 2008 May; 16(10):5606-18. PubMed ID: 18417348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor.
    Jiang W; Tran JA; Tucci FC; Fleck BA; Hoare SR; Markison S; Wen J; Chen CW; Marinkovic D; Arellano M; Foster AC; Chen C
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6546-52. PubMed ID: 17933528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.
    Chen C; Pontillo J; Fleck BA; Gao Y; Wen J; Tran JA; Tucci FC; Marinkovic D; Foster AC; Saunders J
    J Med Chem; 2004 Dec; 47(27):6821-30. PubMed ID: 15615531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist.
    He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Tsou NN; Ball RG; Cashen DE; Martin WJ; Weinberg DH; Macneil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; Macintyre DE; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2106-10. PubMed ID: 20207541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.